Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Van Cott

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Hematology|February 5, 2010
Laboratory monitoring of new anticoagulantsDonna D Castellone, Elizabeth M Van Cott
American Journal of Hematology|March 19, 2019
High frequency of false-positive results of aPTT-based lupus anticoagulant tests in patients receiving argatrobanJulian A Villalba, Elizabeth M Van Cott
International Anesthesiology Clinics|June 19, 2004
Heparin-induced thrombocytopeniaMark E Comunale, Elizabeth M Van Cott
American Journal of Clinical Pathology|April 19, 2007
A new automated screening assay for the diagnosis of von Willebrand diseaseRaneem O Salem, Elizabeth M Van Cott
American Journal of Clinical Pathology|January 23, 2008
Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopeniaKenneth Harris, Phan Nguyen, Elizabeth M Van Cott
American Journal of Hematology|October 9, 2014
Activated protein C resistance testing for factor V LeidenStephan Kadauke, Bernard Khor, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|January 5, 2006
A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive studyAlexander Kratz, Nancy Stanganelli, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|November 8, 2002
Laboratory evaluation of hypercoagulability with venous or arterial thrombosisElizabeth M Van Cott, Michael Laposata, Martin H Prins
Clinics in Laboratory Medicine|July 24, 2002
Hypercoagulability test strategies in the protein C and protein S pathwayElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Pharmacotherapy|March 16, 2005
Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarinPaul A Arpino, Zareh Demirjian, Elizabeth M Van Cott
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Hematology|February 5, 2010
Laboratory monitoring of new anticoagulantsDonna D Castellone, Elizabeth M Van Cott
American Journal of Hematology|March 19, 2019
High frequency of false-positive results of aPTT-based lupus anticoagulant tests in patients receiving argatrobanJulian A Villalba, Elizabeth M Van Cott
International Anesthesiology Clinics|June 19, 2004
Heparin-induced thrombocytopeniaMark E Comunale, Elizabeth M Van Cott
American Journal of Clinical Pathology|April 19, 2007
A new automated screening assay for the diagnosis of von Willebrand diseaseRaneem O Salem, Elizabeth M Van Cott
American Journal of Clinical Pathology|January 23, 2008
Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopeniaKenneth Harris, Phan Nguyen, Elizabeth M Van Cott
American Journal of Hematology|October 9, 2014
Activated protein C resistance testing for factor V LeidenStephan Kadauke, Bernard Khor, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|January 5, 2006
A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive studyAlexander Kratz, Nancy Stanganelli, Elizabeth M Van Cott
Archives of Pathology & Laboratory Medicine|November 8, 2002
Laboratory evaluation of hypercoagulability with venous or arterial thrombosisElizabeth M Van Cott, Michael Laposata, Martin H Prins
Clinics in Laboratory Medicine|July 24, 2002
Hypercoagulability test strategies in the protein C and protein S pathwayElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Pharmacotherapy|March 16, 2005
Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarinPaul A Arpino, Zareh Demirjian, Elizabeth M Van Cott
Pageof 11